2022 Global Alliance for Rapid Diagnostics (GARD) Forum: Bridging Technologies and Market Needs
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Point-of-Care Diagnostics and Devices".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 1039
Special Issue Editor
Interests: nanoparticle-based biosensors; PCR-less genomic detection; genome-phenome approaches to antimicrobial resistance (AMR) detection; beta-lactam (carbapenem) resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The 2022 GARD Forum: Bridging Technologies and Market Needs, to be held on 25–26 February 2022, is a gathering of scientists and practitioners from around the globe to share the state of the art in the development of rapid diagnostics in support of sustainable health in all forms—human, animal, and ecosystem health. In addition, the forum serves as a marketplace where customers’ needs are addressed with innovative technologies, especially to help those in low-resource populations. The event covers 30 hours of continuous programming in various time zones, with different continents holding technical sessions while allowing everyone across borders to join freely.
There are five main activities during the forum:
- Innovation challenge—grassroots and localized identification of problems and solutions through elevator pitches;
- Technical regional sessions—pre-recorded presentations, live talks, and live panel discussions on the conference’s themes;
- Poster presentations—incorporating 3-minute flash talks;
- Short courses—taught by professors from various universities. The courses are: (1) Nanotechnology, (2) Biosensors, (3) R programming, and (4) Entrepreneurship for Scientists;
- Networking.
To participate, please register at: https://bit.ly/gard2022
GARD Forum Website: https://www.egr.msu.edu/alocilja/GARD-location/global-alliance-rapid-diagnostics-gard
Prof. Dr. Evangelyn C. Alocilja
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
